During the past decade, Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály" are "Bladder Cancer" (1 trials), "Cancer" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Drug and/or Toxin-induced Diarrhea" (1 trials) and "Metastatic Castrate Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály" in a lesser frequency.

Most popular intervention types in "Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atezolizumab" (2 trials), "Niraparib" (2 trials), "Prednisone" (2 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály" are 4 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Országos Onkológiai Intézet, C Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".